Global Health Impact Fund
Global Health Impact Fund (GHIF) is a venture capital investment firm based in Walnut Creek, California, established in 2018. The organization focuses on building a network of healthcare professionals who invest in early-stage healthcare technology companies. GHIF aims to empower clinicians and healthcare professionals by providing them with opportunities to actively participate in the evolving landscape of digital health innovation. Through its investor-focused model, GHIF enables its members to engage with a diversified portfolio of startups that are transforming the healthcare industry. The firm emphasizes collaboration and community among healthcare professionals, allowing them to share insights and stay informed about advancements in digital health, including technologies such as AI, telehealth, and genomics. By facilitating this engagement, GHIF seeks to ensure that healthcare professionals are not mere observers but active participants in shaping the future of healthcare.
Based in the Boston biotech and medtech hub, Elucid Bioimaging is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, vascuCAP, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.
Developer of a care management platform intended for patients to follow their treatment plan for musculoskeletal injuries while at home or on the go. The company's platform combines a sensor and a software application where the patients need to wear the sensor near the joint which offers rich predictive analytics for outcomes, enabling doctors to strike a balance between quality, access, and cost and facilitate better remote monitoring for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.